These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7026035)

  • 1. [Activation of plasminogen and prothrombin by immobilized activators -- urokinase and thromboplastin (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Oct; 119(40-41):1106-8. PubMed ID: 7026035
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
    Horie N
    Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):38-45. PubMed ID: 396753
    [No Abstract]   [Full Text] [Related]  

  • 3. Alveolar epithelial cells express both plasminogen activator and tissue factor. Potential role in repair of lung injury.
    Marshall BC; Brown BR; Rothstein MA; Rao NV; Hoidal JR; Rodgers GM
    Chest; 1991 Mar; 99(3 Suppl):25S-27S. PubMed ID: 1900042
    [No Abstract]   [Full Text] [Related]  

  • 4. The biphasic nature and temperature dependence of the activation of human plasminogen by urokinase. A simple urokinase assay based on this phenomenon.
    Ambrus CM; Bartfay-Szabo A; Mirand E; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):339-47. PubMed ID: 461988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator and proactivator (urokinase precursor) in lung cultures.
    Bernik MB; Oller EP
    J Am Med Womens Assoc (1972); 1976 Dec; 31(12):465-72. PubMed ID: 186502
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid.
    Casslén B; Thorell J; Astedt B
    Contraception; 1981 Apr; 23(4):435-45. PubMed ID: 7023822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Compared activation of kinin system by streptokinase and urokinase "in vitro" and during thrombolytic treatments (author's transl)].
    Migne J; Vedrine Y; Conard J; Samama M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():42-7. PubMed ID: 149942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of Immunoassay of Urinary urokinase inhibitor using biological binding activity of urokinase and urokinase inhibitor (author's transl)].
    Yoshio T; Kan S; Ninagawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):451-9. PubMed ID: 7040569
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of the urokinase plasminogen activation system in angiogenesis].
    Smolarz B; Błasiak J; Kulig A
    Postepy Biochem; 2000; 46(3):261-70. PubMed ID: 11138429
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation.
    Geratz JD; Shaver SR; Tidwell RR
    Thromb Res; 1981 Oct 1-15; 24(1-2):73-83. PubMed ID: 6460342
    [No Abstract]   [Full Text] [Related]  

  • 11. Exchange of plasminogen activator between solution and intima.
    Gall W; Gurll NJ; Wright CB; Reynolds DG
    J Surg Res; 1979 May; 26(5):523-7. PubMed ID: 439883
    [No Abstract]   [Full Text] [Related]  

  • 12. The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein.
    Keski-Oja J; Vaheri A
    Biochim Biophys Acta; 1982 Apr; 720(2):141-6. PubMed ID: 7044426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy.
    Weidle UH; Wöllisch E; Rønne E; Ploug M; Behrendt N; de Vries TJ; Quax PH; Verheijen JH; van Muijen GN; Ruiter DJ
    Ann Biol Clin (Paris); 1994; 52(11):775-82. PubMed ID: 7747886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasminogen activation system in lung cancer--with special reference to the prognostic role in "non-small cell lung cancer".
    Pappot H
    APMIS Suppl; 1999; 92():1-29. PubMed ID: 10363031
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor XIIa is a kinetically favorable plasminogen activator.
    Schousboe I; Feddersen K; Røjkjaer R
    Thromb Haemost; 1999 Sep; 82(3):1041-6. PubMed ID: 10494761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.
    Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J
    J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.